Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Sakamoto

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Transplantation Proceedings|December 14, 2020
Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single InstitutionMasaki Iino, Tomoya Sato, Yuma Sakamoto
Hematology (Amsterdam, Netherlands)|September 10, 2019
Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experienceMasaki Iino, Yuma Sakamoto, Tomoya Sato
International Journal of Hematology|June 2, 2020
Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practiceMasaki Iino, Yuma Sakamoto, Tomoya Sato
Hematology (Amsterdam, Netherlands)|March 19, 2019
Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institutionMasaki Iino, Takeo Yamamoto, Yuma Sakamoto
Human Genome Variation|June 9, 2016
A novel type II collagen gene mutation in a family with spondyloepiphyseal dysplasia and extensive intrafamilial phenotypic diversityYasuharu Nakashima, Yuma Sakamoto, Gen Nishimura, et al.
Optics Express|December 23, 2022
Frequency references based on molecular iodine for the study of Yb atoms using the <sup>1</sup>S<sub>0</sub> - <sup>3</sup>P<sub>1</sub> intercombination transition at 556 nmYuto Tanabe, Yuma Sakamoto, Takuya Kohno, et al.
Pathology International|March 26, 2018
Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue studyShusen Han, Ayako Masaki, Yuma Sakamoto, et al.
Clinical Lung Cancer|January 8, 2021
Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation SequencingTadashi Sakane, Yuma Sakamoto, Ayako Masaki, et al.
Immunology|January 29, 2025
Epstein-Barr Virus-Induced 3 Attributes to TLR7-Mediated SplenomegalyMasanori Iseki, Yuma Sakamoto, Daiki Takezaki, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 17, 2016
Screening of the COL2A1 mutation in idiopathic osteonecrosis of the femoral headYuma Sakamoto, Takuaki Yamamoto, Noriko Miyake, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Transplantation Proceedings|December 14, 2020
Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single InstitutionMasaki Iino, Tomoya Sato, Yuma Sakamoto
Hematology (Amsterdam, Netherlands)|September 10, 2019
Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experienceMasaki Iino, Yuma Sakamoto, Tomoya Sato
International Journal of Hematology|June 2, 2020
Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practiceMasaki Iino, Yuma Sakamoto, Tomoya Sato
Hematology (Amsterdam, Netherlands)|March 19, 2019
Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institutionMasaki Iino, Takeo Yamamoto, Yuma Sakamoto
Human Genome Variation|June 9, 2016
A novel type II collagen gene mutation in a family with spondyloepiphyseal dysplasia and extensive intrafamilial phenotypic diversityYasuharu Nakashima, Yuma Sakamoto, Gen Nishimura, et al.
Optics Express|December 23, 2022
Frequency references based on molecular iodine for the study of Yb atoms using the <sup>1</sup>S<sub>0</sub> - <sup>3</sup>P<sub>1</sub> intercombination transition at 556 nmYuto Tanabe, Yuma Sakamoto, Takuya Kohno, et al.
Pathology International|March 26, 2018
Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue studyShusen Han, Ayako Masaki, Yuma Sakamoto, et al.
Clinical Lung Cancer|January 8, 2021
Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation SequencingTadashi Sakane, Yuma Sakamoto, Ayako Masaki, et al.
Immunology|January 29, 2025
Epstein-Barr Virus-Induced 3 Attributes to TLR7-Mediated SplenomegalyMasanori Iseki, Yuma Sakamoto, Daiki Takezaki, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 17, 2016
Screening of the COL2A1 mutation in idiopathic osteonecrosis of the femoral headYuma Sakamoto, Takuaki Yamamoto, Noriko Miyake, et al.
Pageof 4